Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Risk adjusted net present value: What is the current valuation of Eli Lilly and Co's Solbinsiran Sodium?
Solbinsiran Sodium is an antisense rnai oligonucleotide commercialized by Eli Lilly and Co, with a leading Phase II program in...
Data Insights
Risk adjusted net present value: What is the current valuation of Eli Lilly and Co's Solbinsiran Sodium?
Solbinsiran Sodium is an antisense rnai oligonucleotide commercialized by Eli Lilly and Co, with a leading Phase II program in...